These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21557697)

  • 21. Association between serum adipocyte factor level and insulin resistance in polycystic ovarian syndrome.
    Wang Q; Guo T; Tao Y; Wang Q; Song Y; Huang W
    Gynecol Endocrinol; 2011 Nov; 27(11):931-4. PubMed ID: 21495802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum resistin level is a predictor of ovarian response in in vitro fertilisation cycle.
    Chen YC; Tsai EM; Chen HS; Liu YH; Lee CH; Chou FH; Chen IJ; Chen SY; Jong SB; Chan TF
    Acta Obstet Gynecol Scand; 2007; 86(8):963-7. PubMed ID: 17653882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose.
    Tan BK; Adya R; Farhatullah S; Lewandowski KC; O'Hare P; Lehnert H; Randeva HS
    Diabetes; 2008 Apr; 57(4):801-8. PubMed ID: 18174521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS).
    Diamanti-Kandarakis E; Katsikis I; Piperi C; Kandaraki E; Piouka A; Papavassiliou AG; Panidis D
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):634-41. PubMed ID: 18363886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
    Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity?
    Wijeyaratne CN; Nirantharakumar K; Balen AH; Barth JH; Sheriff R; Belchetz PE
    Clin Endocrinol (Oxf); 2004 May; 60(5):560-7. PubMed ID: 15104558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
    Skałba P; Cygal A; Madej P; Dąbkowska-Huć A; Sikora J; Martirosian G; Romanik M; Olszanecka-Glinianowicz M
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The expression of resistin in adipose tissues of patients with polycystic ovary syndrome and insulin resistance.
    Chu Y; Cui Q; Feng G; Song Z; Jiang X
    J Huazhong Univ Sci Technolog Med Sci; 2009 Oct; 29(5):642-5. PubMed ID: 19821101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
    Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
    Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relationship between single nucleotide polymorphism-56 of calpain-10 gene and glucose and lipid metabolism in polycystic ovary syndrome patients].
    Diao XH; Shi YH; Gao Q; Wang LC; Tang R; Chen ZJ
    Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):106-9. PubMed ID: 18683748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of metformin treatment on adiponectin and resistin levels in women with polycystic ovary syndrome: a prospective clinical study.
    Basios G; Trakakis E; Chrelias Ch; Panagopoulos P; Vaggopoulos V; Skarpas P; Kassanos D; Dimitriadis G; Hatziagelaki E
    Gynecol Endocrinol; 2015 Feb; 31(2):136-40. PubMed ID: 25377599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the CD11c gene in subcutaneous adipose tissue is associated with cytokine level and insulin resistance in women with polycystic ovary syndrome.
    Tao T; Li S; Zhao A; Zhang Y; Liu W
    Eur J Endocrinol; 2012 Nov; 167(5):705-13. PubMed ID: 22945299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic characteristics according to insulin sensitivity in non-obese Korean women with polycystic ovary syndrome.
    Park HR; Choi Y; Lee HJ; Oh JY; Hong YS; Sung YA
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S233-7. PubMed ID: 17606307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypothalamic-pituitary-adrenocortical axis hypersensitivity and glucocorticoid receptor expression and function in women with polycystic ovary syndrome.
    Milutinović DV; Macut D; Božić I; Nestorov J; Damjanović S; Matić G
    Exp Clin Endocrinol Diabetes; 2011 Nov; 119(10):636-43. PubMed ID: 22068557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are insulin resistance and serum resistin levels increased in women with idiopathic hirsutism?
    Erkan M; Albayrak M; Karatas A; Keskin F; Aydin Y; Ak HY; Erkan M; Biyik I
    Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1889-95. PubMed ID: 25010619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS; Rouzi AA
    Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome.
    Kuşçu NK; Var A
    Acta Obstet Gynecol Scand; 2009; 88(5):612-7. PubMed ID: 19308750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paraoxonase-1 is not affected in polycystic ovary syndrome without metabolic syndrome and insulin resistance, but oxidative stress is altered.
    Torun AN; Vural M; Cece H; Camuzcuoglu H; Toy H; Aksoy N
    Gynecol Endocrinol; 2011 Dec; 27(12):988-92. PubMed ID: 21557696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.